Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Myrriah Chavez-Tomar"'
Autor:
Zobeida Cruz-Monserrate, Craig D. Logsdon, Ralph B. Arlinghaus, Xiaohong Leng, Huamin Wang, Deyali Chatterjee, Todd Moore, Liran Zhou, Rosa F. Hwang, Defeng Deng, Yan Liu, Carl Schmidt, Thomas A. Mace, Matthew R. Farren, Tanios Bekaii-Saab, Gregory B. Lesinski, Myrriah Chavez-Tomar, Niharika Badi, Agnieszka Katarzyna Swidnicka-Siergiejko, Sobeyda B. Gomez-Chou
Supplementary Table 1. List of antibodies used for immunohistochemical staining of mouse pancreas.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27260b0aa4131c9077d6834aa54bc5fd
https://doi.org/10.1158/0008-5472.22413510
https://doi.org/10.1158/0008-5472.22413510
Autor:
Zobeida Cruz-Monserrate, Craig D. Logsdon, Ralph B. Arlinghaus, Xiaohong Leng, Huamin Wang, Deyali Chatterjee, Todd Moore, Liran Zhou, Rosa F. Hwang, Defeng Deng, Yan Liu, Carl Schmidt, Thomas A. Mace, Matthew R. Farren, Tanios Bekaii-Saab, Gregory B. Lesinski, Myrriah Chavez-Tomar, Niharika Badi, Agnieszka Katarzyna Swidnicka-Siergiejko, Sobeyda B. Gomez-Chou
Lipocalin-2 (LCN2) promotes malignant development in many cancer types. LCN2 is upregulated in patients with pancreatic ductal adenocarcinoma (PDAC) and in obese individuals, but whether it contributes to PDAC development is unclear. In this study, w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::af13bbe5f7a0bd8a30990a5eec838012
https://doi.org/10.1158/0008-5472.c.6508734.v1
https://doi.org/10.1158/0008-5472.c.6508734.v1
Autor:
Zobeida Cruz-Monserrate, Craig D. Logsdon, Ralph B. Arlinghaus, Xiaohong Leng, Huamin Wang, Deyali Chatterjee, Todd Moore, Liran Zhou, Rosa F. Hwang, Defeng Deng, Yan Liu, Carl Schmidt, Thomas A. Mace, Matthew R. Farren, Tanios Bekaii-Saab, Gregory B. Lesinski, Myrriah Chavez-Tomar, Niharika Badi, Agnieszka Katarzyna Swidnicka-Siergiejko, Sobeyda B. Gomez-Chou
Supplementary Table 2. List of human (h) and mouse (m) primer sequences used in study.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6c89aed012c617e349da843fcc071e0
https://doi.org/10.1158/0008-5472.22413507
https://doi.org/10.1158/0008-5472.22413507
Autor:
Zobeida Cruz-Monserrate, Craig D. Logsdon, Ralph B. Arlinghaus, Xiaohong Leng, Huamin Wang, Deyali Chatterjee, Todd Moore, Liran Zhou, Rosa F. Hwang, Defeng Deng, Yan Liu, Carl Schmidt, Thomas A. Mace, Matthew R. Farren, Tanios Bekaii-Saab, Gregory B. Lesinski, Myrriah Chavez-Tomar, Niharika Badi, Agnieszka Katarzyna Swidnicka-Siergiejko, Sobeyda B. Gomez-Chou
Additional Experimental Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4f745e6a71b37bb18ae55928d0994cf
https://doi.org/10.1158/0008-5472.22413501
https://doi.org/10.1158/0008-5472.22413501
Autor:
Valentina Pita-Grisanti, Kelly Dubay, Ali Lahooti, Niharika Badi, Olivia Ueltschi, Kristyn Gumpper-Fedus, Hsiang-Yin Hsueh, Ila Lahooti, Myrriah Chavez-Tomar, Samantha Terhorst, Sue E. Knoblaugh, Lei Cao, Wei Huang, Christopher C. Coss, Thomas A. Mace, Fouad Choueiry, Alice Hinton, Jennifer M Mitchell, Rosemarie Schmandt, Michaela Onstad Grinsfelder, Karen Basen-Engquist, Zobeida Cruz-Monserrate
BACKGROUND & AIMSObesity is a risk factor for pancreatic ductal adenocarcinoma (PDAC), a deadly disease with limited preventive strategies. Lifestyle interventions to decrease obesity might prevent obesity-associated PDAC. Here, we examined whether d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c82ed8042beb2fad95158dbe777544c7
https://doi.org/10.1101/2023.01.03.521203
https://doi.org/10.1101/2023.01.03.521203
Autor:
Zobeida Cruz-Monserrate, Keri Schadler, Valentina Pita-Grisanti, Kristyn Gumpper-Fedus, Ali Lahooti, Hsiang-Yin Hsueh, Myrriah Chavez-Tomar
Publikováno v:
Pancreatology
Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest types of cancer, and the increasing incidence of PDAC may be related to the prevalence of obesity. Physical activity (PA), a method known to mitigate obesity by increasing total energy e
Autor:
Liran Zhou, Carl Schmidt, Zobeida Cruz-Monserrate, Gregory B. Lesinski, Thomas A. Mace, Rosa F. Hwang, Sobeyda B. Gomez-Chou, Matthew R. Farren, Yan Liu, Huamin Wang, Todd Moore, Tanios Bekaii-Saab, Craig D. Logsdon, Niharika Badi, Defeng Deng, Xiaohong Leng, Deyali Chatterjee, Agnieszka Katarzyna Swidnicka-Siergiejko, Ralph B. Arlinghaus, Myrriah Chavez-Tomar
Publikováno v:
Cancer Research. 77:2647-2660
Lipocalin-2 (LCN2) promotes malignant development in many cancer types. LCN2 is upregulated in patients with pancreatic ductal adenocarcinoma (PDAC) and in obese individuals, but whether it contributes to PDAC development is unclear. In this study, w
Autor:
Samantha Terhorst, Niharika Badi, Jennifer M. Mitchell, Karen Basen-Engquist, Alice Hinton, Kelly Dubay, Myrriah Chavez-Tomar, Thomas A. Mace, Valentina Pita-Grisanti, Fouad Choueiry, Zobeida Cruz-Monserrate, Ali Lahooti, Olivia Ueltschi, Christopher C. Coss, Sue E. Knoblaugh
Publikováno v:
Cancer Research. 80:PO-034
Background: Obesity is a risk factor for pancreatic ductal adenocarcinoma (PDAC), a deadly disease with no preventive strategies. Lifestyle interventions to decrease obesity might serve to prevent obesity-induced PDAC. We examined whether decreasing